Clinical Trial Update: The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the safety and potential efficacy of a single dose of CARC-101C in patients with Type 1 diabetes mellitus, with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CARC-101C

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Autoimmune Type 1 Diabetes Mellitus(T1DM) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING